177 related articles for article (PubMed ID: 10365126)
1. Flow cytometric analysis of DNA-aneuploidy subgroups and proliferation in renal cell carcinoma.
Schafhauser W; Liedl T; Elsässer D; Zörcher T; Schrott KM
Anticancer Res; 1999; 19(2C):1471-5. PubMed ID: 10365126
[TBL] [Abstract][Full Text] [Related]
2. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma.
Yokogi H
Cancer; 1996 Aug; 78(4):819-26. PubMed ID: 8756377
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of flow cytometric, static cytometry and tumor cytogenetic investigation results human renal cell carcinomas].
Krech RH; Baretton G; Fonatsch C; Diebold J; Früchtnicht W; Löhrs U
Verh Dtsch Ges Pathol; 1990; 74():228-32. PubMed ID: 1708590
[TBL] [Abstract][Full Text] [Related]
5. DNA cytophotometry in renal cell carcinoma: a significant prognostic factor?
Feil G; Mittermüller B; Bichler KH; Wunderer A; Wechsel HW; Nelde HJ; St Krause F
Anticancer Res; 1999; 19(2C):1483-6. PubMed ID: 10365128
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
[TBL] [Abstract][Full Text] [Related]
8. The in vivo DNA aneuploidization during expansion of conventional renal cell carcinoma.
Li G; Cottier M; Sabido O; Gentil-Perret A; Lambert C; Passebosc-Faure K; Genin C; Tostain J
In Vivo; 2002; 16(5):341-4. PubMed ID: 12494875
[TBL] [Abstract][Full Text] [Related]
9. DNA cytometry in renal cell carcinoma.
Nenning H; Rassler J; Minh DH
Gen Diagn Pathol; 1996 Mar; 141(3-4):243-7. PubMed ID: 8705789
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: its correlation with histopathology and prognosis.
Yu DS; Hsu CM; Lee WH; Chang SY; Ma CP
J Surg Res; 1993 Nov; 55(5):480-5. PubMed ID: 8231166
[TBL] [Abstract][Full Text] [Related]
11. Clinical and flow cytometric analyses of renal cell carcinomas with reference to incidental or non-incidental detection.
Sasaki Y; Homma Y; Hosaka Y; Tajima A; Aso Y
Jpn J Clin Oncol; 1994 Feb; 24(1):32-6. PubMed ID: 8126918
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and corresponding flow cytometric DNA analysis of renal cell neoplasms.
el-Naggar AK; Pathak S
Anticancer Res; 1992; 12(5):1491-500. PubMed ID: 1444211
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
[TBL] [Abstract][Full Text] [Related]
14. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis?
Skolarikos A; Alivizatos G; Bamias A; Mitropoulos D; Ferakis N; Deliveliotis C; Dimopoulos MA
Int J Urol; 2005 Jun; 12(6):563-9. PubMed ID: 15985079
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy status and DNA content instability within single tumors in renal cell carcinoma.
Bringuier PP; Bouvier R; Berger N; Piaton E; Revillard JP; Perrin P; Devonec M
Cytometry; 1993; 14(5):559-64. PubMed ID: 8354129
[TBL] [Abstract][Full Text] [Related]
17. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
Eskelinen M; Lipponen P; Nordling S
Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
19. [Flow cytometric analysis of renal cell carcinoma].
Lü GH
Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):27-9. PubMed ID: 2364867
[TBL] [Abstract][Full Text] [Related]
20. In vivo aneuploidization during the expansion of renal adenocarcinoma.
Di Capua Sacoto C; Budia Alba A; Alapont Alacreu JM; Ruiz Cerda JL; Jimenez Cruz JF
Urol Int; 2011; 86(4):466-9. PubMed ID: 21546757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]